• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10619
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Arteriosclerosis/ Atherosclerosis (4437)
Event Date 10/24/2023
Event Type  Injury  
Event Description
Synergy china registry it was reported that the patient experienced coronary atherosclerotic heart disease.In (b)(6) 2020, the subject was referred for cardiac catheterization and index procedure was performed on the same day.The target lesion was located in the left main coronary artery (lmca) extending up to proximal left anterior descending (lad) artery with 90 % stenosis and was 18 mm long, with a reference vessel diameter of 3.8 mm.The target lesion was treated with pre-dilatation and placement of a 4.00 mm x 20 mm synergy stent system.Following post-dilatation, the residual stenosis was noted to be 0%.Six days later, subject was discharged on aspirin and ticagrelor.In (b)(6) 2023, the subject was diagnosed with coronary atherosclerotic heart disease and was hospitalized on the same day for further treatment.On the next day, the subject was referred for coronary angiography which revealed 100% stenosis noted in lmca extending up to proximal lad which had previously placed study device was treated with percutaneous coronary intervention.Post intervention, the residual stenosis was 0%.Target vessel revascularization was performed, and medication was given to treat the event.One week later, the event was considered to be recovered/resolved and on the same day the subject was discharged on aspirin and ticagrelor.
 
Manufacturer Narrative
E1 initial reporter phone: (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18361168
MDR Text Key330933448
Report Number2124215-2023-71724
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/05/2022
Device Model Number10619
Device Catalogue Number10619
Device Lot Number0025076485
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/12/2023
Initial Date FDA Received12/19/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/06/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age72 YR
Patient SexMale
-
-